domperidone has been researched along with prazosin in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (46.15) | 18.7374 |
| 1990's | 2 (7.69) | 18.2507 |
| 2000's | 5 (19.23) | 29.6817 |
| 2010's | 5 (19.23) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Janssen, CG; Laduron, PM; Thijssen, JB; Van Dun, J; Wouters, W | 1 |
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Sen, S; Sinha, N | 1 |
| Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Esaki, T; Kawashima, H; Komura, H; Kuroda, M; Mizuguchi, K; Natsume-Kitatani, Y; Ohashi, R; Watanabe, R | 1 |
| Acevedo, O; Dasararaju, G; Devadasan, V; Halakova, D; Jayaprakash, V; Kovacikova, L; Mohd Siddique, MU; Mondal, SK; Prnova, MS; Shilkar, D; Stefek, M; Thakur, A; Yasmin, S | 1 |
| Martínez, JA; Milanés, MV; Vargas, ML | 1 |
| Fujiwara, M; Nishikawa, H; Taniguchi, T; Yokotani, K | 1 |
| Greiner, HE; Haase, A; Klockow, M; Schmitges, CJ; Seyfried, C | 1 |
| Emi, S; Hikasa, Y; Ogasawara, S; Takase, K | 1 |
| Böhmer, G; Gouzoulis, E; Löffelholz, K; Raach, M; Schmid, K | 1 |
| Carroll, JD; Itoh, H; Lang, RM; Nakamura, S; Rajfer, SI | 1 |
| Delpierre, S; Grimaud, C; Guillot, C; Peyrot, J | 1 |
| Schuurkes, JA; Van Nueten, JM | 3 |
| Bohmann, C; Riera-Knorrenschild, G; Rump, LC; Schollmeyer, P; Schwertfeger, E; Spillner, G | 1 |
| Rossi, NF | 1 |
26 other study(ies) available for domperidone and prazosin
| Article | Year |
|---|---|
In vitro labeling of serotonin-S2 receptors: synthesis and binding characteristics of [3H]-7-aminoketanserin.
Topics: Animals; Binding, Competitive; Brain; Chemical Phenomena; Chemistry; Frontal Lobe; Guinea Pigs; Ketanserin; Kinetics; Piperidines; Rats; Rats, Inbred Strains; Receptors, Serotonin | 1986 |
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of an
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Cell Line; Computer Simulation; Endothelial Cells; Gene Knockout Techniques; Humans; Organic Chemicals; Rats, Transgenic | 2021 |
Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives.
Topics: Aldehyde Reductase; Animals; Caco-2 Cells; Catalytic Domain; Dogs; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Madin Darby Canine Kidney Cells; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Protein Binding; Rats, Wistar; Structure-Activity Relationship; Thiazolidinediones | 2021 |
Influence of dopaminergic and noradrenergic systems on the release of opioid peptides in guinea-pig ileum.
Topics: Adrenergic alpha-Antagonists; Animals; Domperidone; Dopamine; Endorphins; Female; Guinea Pigs; Ileum; In Vitro Techniques; Male; Muscle, Smooth; Myenteric Plexus; Naloxone; Norepinephrine; Piperidines; Prazosin; Receptors, Dopamine; Yohimbine | 1989 |
The bindings of 3H-prazosin and 3H-yohimbine to alpha adrenoceptors in the guinea-pig stomach.
Topics: Animals; Apomorphine; Binding, Competitive; Cell Membrane; Domperidone; Dopamine; Gastric Mucosa; Guinea Pigs; Male; Prazosin; Receptors, Adrenergic, alpha; Spiperone; Sympatholytics; Sympathomimetics; Tritium; Yohimbine | 1988 |
Studies on the receptor profile of bisoprolol.
Topics: Adrenergic beta-Antagonists; Animals; Binding, Competitive; Bisoprolol; Cattle; Dihydroalprenolol; Domperidone; Humans; In Vitro Techniques; Ketanserin; Male; Piperidines; Prazosin; Propanolamines; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Histamine; Receptors, Muscarinic; Spiperone; Tetrahydronaphthalenes; Yohimbine | 1986 |
Antagonistic effects of alpha-adrenoceptor blocking agents on reticuloruminal hypomotility induced by xylazine in cattle.
Topics: Adrenergic alpha-Antagonists; Animals; Cattle; Domperidone; Female; Gastrointestinal Motility; Naloxone; Prazosin; Reticulum; Rumen; Thiazines; Tolazoline; Xylazine; Yohimbine | 1988 |
Dopaminergic control of respiration as shown by effects of 4-aminopyridine.
Topics: 4-Aminopyridine; Aminopyridines; Anesthesia; Animals; Atropine; Domperidone; Dopamine; Haloperidol; Hemodynamics; Neuromuscular Depolarizing Agents; Phrenic Nerve; Prazosin; Rabbits; Respiration; Salivation; Vagotomy | 1986 |
Role of adrenoceptors and dopamine receptors in modulating left ventricular diastolic function.
Topics: Animals; Diastole; Dobutamine; Dogs; Domperidone; Dopamine; Hemodynamics; Myocardial Contraction; Prazosin; Receptors, Adrenergic; Receptors, Dopamine; Systole; Ventricular Function; Yohimbine | 1988 |
Ventilatory effects of domperidone, a new dopamine antagonist, in anaesthetized rabbits.
Topics: Anesthesia; Animals; Blood Gas Analysis; Carbon Dioxide; Domperidone; Dopamine Antagonists; Heart Rate; Hydrogen-Ion Concentration; Hypoxia; Oxygen Consumption; Prazosin; Rabbits; Respiration | 1985 |
Effects of dopamine and its antagonist domperidone cannot be explained by an effect on alpha 1-adrenergic receptors.
Topics: Animals; Benzimidazoles; Domperidone; Dopamine; Dopamine Antagonists; Guinea Pigs; In Vitro Techniques; Muscle Contraction; Phenylephrine; Piperidines; Prazosin; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Stomach | 1981 |
Dose-dependent stimulation of antroduodenal coordination by domperidone via specific dopamine-receptors.
Topics: Animals; Domperidone; Duodenum; Guinea Pigs; In Vitro Techniques; Peristalsis; Prazosin; Propranolol; Pyloric Antrum; Receptors, Adrenergic, alpha; Receptors, Dopamine; Stimulation, Chemical | 1982 |
Is dopamine an inhibitory modulator of gastrointestinal motility?
Topics: Animals; Benzimidazoles; Domperidone; Dopamine; Dopamine Antagonists; Gastrointestinal Motility; Guinea Pigs; Piperidines; Prazosin | 1981 |
Dopaminergic and alpha-adrenergic control of neurotransmission in human right atrium.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Aged; Benzazepines; Brimonidine Tartrate; Domperidone; Dopamine Agonists; Dopamine Antagonists; Electric Stimulation; Ergolines; Female; Fenoldopam; Heart Atria; Humans; In Vitro Techniques; Male; Methoxamine; Middle Aged; Norepinephrine; Prazosin; Quinoxalines; Quinpirole; Receptors, Adrenergic, alpha; Receptors, Dopamine; Sulpiride; Synaptic Transmission; Yohimbine | 1995 |
Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Angiotensin II; Animals; Apomorphine; Arginine Vasopressin; Benzazepines; Domperidone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Hypothalamo-Hypophyseal System; Kinetics; Male; Models, Neurological; Organ Culture Techniques; Phenoxybenzamine; Prazosin; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Receptors, Dopamine D2; Time Factors | 1998 |